Success Metrics

Clinical Success Rate
100.0%

Based on 9 completed trials

Completion Rate
100%(9/9)
Active Trials
4(24%)
Results Posted
44%(4 trials)

Phase Distribution

Ph phase_1
2
12%
Ph not_applicable
15
88%

Phase Distribution

2

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution17 total trials
Phase 1Safety & dosage
2(11.8%)
N/ANon-phased studies
15(88.2%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

100.0%

9 of 9 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

4

trials recruiting

Total Trials

17

all time

Status Distribution
Active(6)
Completed(9)
Other(2)

Detailed Status

Completed9
Recruiting3
Enrolling by invitation2
unknown2
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
17
Active
4
Success Rate
100.0%
Most Advanced
Phase 1

Trials by Phase

Phase 12 (11.8%)
N/A15 (88.2%)

Trials by Status

enrolling_by_invitation212%
unknown212%
completed953%
recruiting318%
active_not_recruiting16%

Recent Activity

4 active trials
Showing 5 of 17
recruitingnot_applicable

Intermittent Hypoxia in Persons With Multiple Sclerosis

NCT06276634
enrolling_by_invitationnot_applicable

Effect of Intermittent Hypoxia in Healthy Individuals

NCT04691518
recruitingnot_applicable

Effects of Acute Intermittent Hypoxia on Neuroplasticity in MS

NCT06390930
active_not_recruitingnot_applicable

The Synergistic Effects of AIH and FES in Persons With MS

NCT06413602
completednot_applicable

Acute Intermittent Hypoxia in Traumatic Brain Injury

NCT04890639
View all 17 trials

Clinical Trials (17)

Showing 17 of 17 trials
NCT06276634Not Applicable

Intermittent Hypoxia in Persons With Multiple Sclerosis

Recruiting
NCT04691518Not Applicable

Effect of Intermittent Hypoxia in Healthy Individuals

Enrolling By Invitation
NCT06390930Not Applicable

Effects of Acute Intermittent Hypoxia on Neuroplasticity in MS

Recruiting
NCT06413602Not Applicable

The Synergistic Effects of AIH and FES in Persons With MS

Active Not Recruiting
NCT04890639Not Applicable

Acute Intermittent Hypoxia in Traumatic Brain Injury

Completed
NCT05848778Not Applicable

Non-invasive Therapy to Drive Nerve Regeneration

Enrolling By Invitation
NCT06614309Not Applicable

Non-invasive Treatment for Long COVID (Post COVID-19 Condition) Brain Fog

Recruiting
NCT03645031Not Applicable

Acute Intermittent Hypoxia and Breathing in Neuromuscular Disease

Completed
NCT05341466Not Applicable

The Effect of Acute Intermittent Hypoxia on Motor Learning

Completed
NCT05164705Not Applicable

Improving Human Cerebrovascular Function Using Acute Intermittent Hypoxia

Completed
NCT05183113Not Applicable

Measuring the Neurological Benefits of Intermittent Hypoxia Therapy With MRI

Completed
NCT05513911Not Applicable

Intermittent Hypoxia and Upper Extremity EMG Recordings in Individuals With Spinal Cord Injury

Completed
NCT03957213Not Applicable

Enhancing Cognition in Older Adults With Intermittent Hypoxia and Cognitive Training

Completed
NCT03774043Phase 1

Timing and Dosage of Acute Intermittent Hypoxia in Persons With SCI

Unknown
NCT03453697Not Applicable

Effects of Acute Intermittent Hypoxia on Brain Function Imaging and Systemic Inflammation

Unknown
NCT02441179Not Applicable

Acute Intermittent Hypoxia and Body Weight Supported Treadmill Training for Incomplete Spinal Cord Injury Patients

Completed
NCT01272349Phase 1

Intermittent Hypoxia Elicits Prolonged Restoration of Motor Function in Human SCI

Completed

All 17 trials loaded

Drug Details

Intervention Type
OTHER
Total Trials
17